ID   RIOK3_HUMAN             Reviewed;         519 AA.
AC   O14730; Q8IXN9;
DT   07-DEC-2004, integrated into UniProtKB/Swiss-Prot.
DT   20-FEB-2007, sequence version 2.
DT   10-MAY-2017, entry version 148.
DE   RecName: Full=Serine/threonine-protein kinase RIO3;
DE            EC=2.7.11.1;
DE   AltName: Full=RIO kinase 3;
DE   AltName: Full=sudD homolog;
GN   Name=RIOK3; Synonyms=SUDD;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND TISSUE SPECIFICITY.
RX   PubMed=9602165; DOI=10.1016/S0378-1119(98)00115-2;
RA   Anaya P., Evans S.C., Dai C., Lozano G., May G.S.;
RT   "Isolation of the Aspergillus nidulans sudD gene and its human
RT   homologue.";
RL   Gene 211:323-329(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16177791; DOI=10.1038/nature03983;
RA   Nusbaum C., Zody M.C., Borowsky M.L., Kamal M., Kodira C.D.,
RA   Taylor T.D., Whittaker C.A., Chang J.L., Cuomo C.A., Dewar K.,
RA   FitzGerald M.G., Yang X., Abouelleil A., Allen N.R., Anderson S.,
RA   Bloom T., Bugalter B., Butler J., Cook A., DeCaprio D., Engels R.,
RA   Garber M., Gnirke A., Hafez N., Hall J.L., Norman C.H., Itoh T.,
RA   Jaffe D.B., Kuroki Y., Lehoczky J., Lui A., Macdonald P., Mauceli E.,
RA   Mikkelsen T.S., Naylor J.W., Nicol R., Nguyen C., Noguchi H.,
RA   O'Leary S.B., Piqani B., Smith C.L., Talamas J.A., Topham K.,
RA   Totoki Y., Toyoda A., Wain H.M., Young S.K., Zeng Q., Zimmer A.R.,
RA   Fujiyama A., Hattori M., Birren B.W., Sakaki Y., Lander E.S.;
RT   "DNA sequence and analysis of human chromosome 18.";
RL   Nature 437:551-555(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-122; SER-127 AND
RP   SER-128, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [5]
RP   FUNCTION, INTERACTION WITH CASP10, MUTAGENESIS OF LYS-290, AND
RP   PHOSPHORYLATION.
RX   PubMed=19557502; DOI=10.1007/s11010-009-0180-8;
RA   Shan J., Wang P., Zhou J., Wu D., Shi H., Huo K.;
RT   "RIOK3 interacts with caspase-10 and negatively regulates the NF-
RT   kappaB signaling pathway.";
RL   Mol. Cell. Biochem. 332:113-120(2009).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [7]
RP   SUBUNIT.
RX   PubMed=22072790; DOI=10.1091/mbc.E11-07-0639;
RA   Widmann B., Wandrey F., Badertscher L., Wyler E., Pfannstiel J.,
RA   Zemp I., Kutay U.;
RT   "The kinase activity of human Rio1 is required for final steps of
RT   cytoplasmic maturation of 40S subunits.";
RL   Mol. Biol. Cell 23:22-35(2012).
RN   [8]
RP   FUNCTION, SUBCELLULAR LOCATION, AND SUBUNIT.
RX   PubMed=22418843; DOI=10.4161/rna.18810;
RA   Baumas K., Soudet J., Caizergues-Ferrer M., Faubladier M., Henry Y.,
RA   Mougin A.;
RT   "Human RioK3 is a novel component of cytoplasmic pre-40S pre-ribosomal
RT   particles.";
RL   RNA Biol. 9:162-174(2012).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-8 AND SER-112, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [10]
RP   FUNCTION, INTERACTION WITH IRF3, AND MUTAGENESIS OF LYS-290.
RX   PubMed=24807708; DOI=10.1128/JVI.00643-14;
RA   Feng J., De Jesus P.D., Su V., Han S., Gong D., Wu N.C., Tian Y.,
RA   Li X., Wu T.T., Chanda S.K., Sun R.;
RT   "RIOK3 is an adaptor protein required for IRF3-mediated antiviral type
RT   I interferon production.";
RL   J. Virol. 88:7987-7997(2014).
RN   [11]
RP   FUNCTION.
RX   PubMed=25865883; DOI=10.1016/j.celrep.2015.03.027;
RA   Takashima K., Oshiumi H., Takaki H., Matsumoto M., Seya T.;
RT   "RIOK3-mediated phosphorylation of MDA5 interferes with its assembly
RT   and attenuates the innate immune response.";
RL   Cell Rep. 11:192-200(2015).
RN   [12]
RP   VARIANTS [LARGE SCALE ANALYSIS] VAL-336; GLN-441 AND LEU-447.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Involved in regulation of type I interferon (IFN)-
CC       dependent immune response which plays a critical role in the
CC       innate immune response against DNA and RNA viruses. May act as an
CC       adapter protein essential for the recruitment of TBK1 to IRF3
CC       (PubMed:24807708). Phosphorylates IFIH1 on 'Ser-828' interfering
CC       with IFIH1 filament assembly on long dsRNA and resulting in
CC       attenuated IFIH1-signaling (PubMed:25865883). Can inhibit CASP10
CC       isoform 7-mediated activation of the NF-kappaB signaling pathway
CC       (PubMed:19557502). May play a role in the biogenesis of the 40S
CC       ribosomal subunit. Involved in the processing of 21S pre-rRNA to
CC       the mature 18S rRNA (PubMed:22418843).
CC       {ECO:0000269|PubMed:19557502, ECO:0000269|PubMed:22418843,
CC       ECO:0000269|PubMed:24807708, ECO:0000269|PubMed:25865883}.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000305};
CC   -!- SUBUNIT: Interacts with CASP10 (PubMed:19557502). Interacts with
CC       IRF3; RIOK3 probybly mediates the interaction of TBK1 with IRF3
CC       (PubMed:24807708). Associated with 40S pre-ribosomal particles.
CC       {ECO:0000269|PubMed:19557502, ECO:0000269|PubMed:22072790,
CC       ECO:0000269|PubMed:22418843}.
CC   -!- INTERACTION:
CC       Q92851:CASP10; NbExp=6; IntAct=EBI-1047061, EBI-495095;
CC       Q92851-7:CASP10; NbExp=3; IntAct=EBI-1047061, EBI-12737837;
CC       Q9BYX4:IFIH1; NbExp=6; IntAct=EBI-1047061, EBI-6115771;
CC       Q14653:IRF3; NbExp=6; IntAct=EBI-1047061, EBI-2650369;
CC       Q9UHD2:TBK1; NbExp=3; IntAct=EBI-1047061, EBI-356402;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:22418843}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=O14730-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O14730-2; Sequence=VSP_012164;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Widely expressed.
CC       {ECO:0000269|PubMed:9602165}.
CC   -!- PTM: Autophosphorylated (in vitro). {ECO:0000269|PubMed:19557502}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. RIO-type
CC       Ser/Thr kinase family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF013591; AAC26080.1; -; mRNA.
DR   EMBL; AC026634; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC039729; AAH39729.1; -; mRNA.
DR   CCDS; CCDS11877.1; -. [O14730-1]
DR   RefSeq; NP_003822.2; NM_003831.4. [O14730-1]
DR   UniGene; Hs.445511; -.
DR   UniGene; Hs.728452; -.
DR   ProteinModelPortal; O14730; -.
DR   SMR; O14730; -.
DR   BioGrid; 114309; 26.
DR   IntAct; O14730; 17.
DR   STRING; 9606.ENSP00000341874; -.
DR   BindingDB; O14730; -.
DR   ChEMBL; CHEMBL5659; -.
DR   GuidetoPHARMACOLOGY; 2188; -.
DR   iPTMnet; O14730; -.
DR   PhosphoSitePlus; O14730; -.
DR   BioMuta; RIOK3; -.
DR   EPD; O14730; -.
DR   MaxQB; O14730; -.
DR   PaxDb; O14730; -.
DR   PeptideAtlas; O14730; -.
DR   PRIDE; O14730; -.
DR   DNASU; 8780; -.
DR   Ensembl; ENST00000339486; ENSP00000341874; ENSG00000101782. [O14730-1]
DR   Ensembl; ENST00000577501; ENSP00000462548; ENSG00000101782. [O14730-2]
DR   GeneID; 8780; -.
DR   KEGG; hsa:8780; -.
DR   UCSC; uc002kui.5; human. [O14730-1]
DR   CTD; 8780; -.
DR   DisGeNET; 8780; -.
DR   GeneCards; RIOK3; -.
DR   HGNC; HGNC:11451; RIOK3.
DR   HPA; HPA001620; -.
DR   HPA; HPA024184; -.
DR   MIM; 603579; gene.
DR   neXtProt; NX_O14730; -.
DR   OpenTargets; ENSG00000101782; -.
DR   PharmGKB; PA36248; -.
DR   eggNOG; KOG2269; Eukaryota.
DR   eggNOG; COG1718; LUCA.
DR   GeneTree; ENSGT00390000004370; -.
DR   HOGENOM; HOG000007623; -.
DR   HOVERGEN; HBG057475; -.
DR   InParanoid; O14730; -.
DR   KO; K08872; -.
DR   OMA; SFIGQDQ; -.
DR   OrthoDB; EOG091G064C; -.
DR   PhylomeDB; O14730; -.
DR   TreeFam; TF105831; -.
DR   Reactome; R-HSA-6791226; Major pathway of rRNA processing in the nucleolus and cytosol.
DR   ChiTaRS; RIOK3; human.
DR   GenomeRNAi; 8780; -.
DR   PRO; PR:O14730; -.
DR   Proteomes; UP000005640; Chromosome 18.
DR   Bgee; ENSG00000101782; -.
DR   CleanEx; HS_RIOK3; -.
DR   ExpressionAtlas; O14730; baseline and differential.
DR   Genevisible; O14730; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0030688; C:preribosome, small subunit precursor; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0089720; F:caspase binding; IDA:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB.
DR   GO; GO:1990786; P:cellular response to dsDNA; IMP:UniProtKB.
DR   GO; GO:0071359; P:cellular response to dsRNA; IMP:UniProtKB.
DR   GO; GO:0098586; P:cellular response to virus; IMP:UniProtKB.
DR   GO; GO:0007059; P:chromosome segregation; TAS:ProtInc.
DR   GO; GO:0051607; P:defense response to virus; IEA:UniProtKB-KW.
DR   GO; GO:0045087; P:innate immune response; IEA:UniProtKB-KW.
DR   GO; GO:0030490; P:maturation of SSU-rRNA; IMP:UniProtKB.
DR   GO; GO:0043124; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; IDA:UniProtKB.
DR   GO; GO:0039534; P:negative regulation of MDA-5 signaling pathway; IMP:UniProtKB.
DR   GO; GO:0032463; P:negative regulation of protein homooligomerization; IDA:UniProtKB.
DR   GO; GO:0045089; P:positive regulation of innate immune response; IMP:UniProtKB.
DR   GO; GO:0032728; P:positive regulation of interferon-beta production; IMP:UniProtKB.
DR   GO; GO:0006364; P:rRNA processing; TAS:Reactome.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000687; RIO_kinase.
DR   InterPro; IPR018935; RIO_kinase_CS.
DR   InterPro; IPR017406; Ser/Thr_kinase_Rio3.
DR   PANTHER; PTHR10593:SF75; PTHR10593:SF75; 1.
DR   PIRSF; PIRSF038146; Ser/Thr_PK_RIO3; 1.
DR   SMART; SM00090; RIO; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS01245; RIO1; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Antiviral defense; ATP-binding;
KW   Complete proteome; Cytoplasm; Immunity; Innate immunity; Kinase;
KW   Magnesium; Metal-binding; Nucleotide-binding; Phosphoprotein;
KW   Polymorphism; Reference proteome; Ribosome biogenesis;
KW   Serine/threonine-protein kinase; Transferase.
FT   CHAIN         1    519       Serine/threonine-protein kinase RIO3.
FT                                /FTId=PRO_0000213529.
FT   DOMAIN      251    519       Protein kinase.
FT   NP_BIND     257    265       ATP. {ECO:0000250}.
FT   ACT_SITE    406    406       Proton acceptor. {ECO:0000250}.
FT   BINDING     290    290       ATP. {ECO:0000250}.
FT   MOD_RES       8      8       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     112    112       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     122    122       Phosphotyrosine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES     125    125       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9DBU3}.
FT   MOD_RES     127    127       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES     128    128       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   VAR_SEQ     449    451       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_012164.
FT   VARIANT     336    336       L -> V (in dbSNP:rs35401850).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042355.
FT   VARIANT     441    441       R -> Q (in dbSNP:rs33969048).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042356.
FT   VARIANT     447    447       S -> L (in dbSNP:rs56282762).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042357.
FT   MUTAGEN     290    290       K->A: Decreases autophosphorylation (in
FT                                vitro); abolishes inhibition of TNF-
FT                                alpha-induced NF-kappaB activation; no
FT                                effect on interaction with IRF3; fails to
FT                                activate IFN-beta promoter and IRF3
FT                                phosphorylation.
FT                                {ECO:0000269|PubMed:19557502,
FT                                ECO:0000269|PubMed:24807708}.
FT   CONFLICT    325    325       I -> H (in Ref. 1; AAC26080).
FT                                {ECO:0000305}.
SQ   SEQUENCE   519 AA;  59093 MW;  3C3392BAC4ECB912 CRC64;
     MDLVGVASPE PGTAAAWGPS KCPWAIPQNT ISCSLADVMS EQLAKELQLE EEAAVFPEVA
     VAEGPFITGE NIDTSSDLML AQMLQMEYDR EYDAQLRREE KKFNGDSKVS ISFENYRKVH
     PYEDSDSSED EVDWQDTRDD PYRPAKPVPT PKKGFIGKGK DITTKHDEVV CGRKNTARME
     NFAPEFQVGD GIGMDLKLSN HVFNALKQHA YSEERRSARL HEKKEHSTAE KAVDPKTRLL
     MYKMVNSGML ETITGCISTG KESVVFHAYG GSMEDEKEDS KVIPTECAIK VFKTTLNEFK
     NRDKYIKDDF RFKDRFSKLN PRKIIRMWAE KEMHNLARMQ RAGIPCPTVV LLKKHILVMS
     FIGHDQVPAP KLKEVKLNSE EMKEAYYQTL HLMRQLYHEC TLVHADLSEY NMLWHAGKVW
     LIDVSQSVEP THPHGLEFLF RDCRNVSQFF QKGGVKEALS ERELFNAVSG LNITADNEAD
     FLAEIEALEK MNEDHVQKNG RKAASFLKDD GDPPLLYDE
//
